Gedeon Richter - PregLem S.A.
Simeon Ocran is a Senior Global Study Manager at Roche. Prior to this role, Simeon held similar positions at Axial Therapeutics, Inc. and Gedeon Richter - PregLem S.A. Simeon has a background in microbiology, holding an MS from Northeastern University and a BS from Leibniz Universität Hannover. Additionally, Simeon holds a certificate in Project Management from Boston University and is a Project Management Professional Certification (PMP®) holder from the Project Management Institute.
Gedeon Richter - PregLem S.A.
PregLem is a Swiss-based specialty biopharmaceutical company dedicated to the development and commercialisation of innovative drugs for women’s reproductive medicine. The company was founded in 2006 by Ernest Loumaye, a specialist in female reproductive medicine, and Eric Rolin, a finance executive in the pharmaceutical industry. PregLem’s name reflects the company’s goal of addressing unmet needs in gynaecology and infertility and its geographical location near Lake Geneva (“Lac Leman” in French). PregLem is supported by a Scientific Advisory Board comprising the heads of reproductive medicine departments from major European academic institutions. PregLem’s team expertise is in Clinical Product Development, Regulatory Affairs and Sales and Marketing of innovative products in women’s health. On 7th October 2010, Gedeon Richter Plc. announced the acquisition of PregLem SA and PregLem became a member of the Richter Group.